跳至主要内容
临床试验/ACTRN12615000952549
ACTRN12615000952549终止2 期

A Randomized Controlled Study of Ferric Carboxymaltose versus Placebo in Patients with Heart Failure on Short Term Outcomes including quality of life, exercise tolerance, hemodynamic indices, serum BNP and ST2 levels

Professor Andrew Sindone0 个研究点目标入组 82 人开始时间: 2015年9月10日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1) Chronic Heart Failure
  • 2) Iron Deficiency
  • 3) Patient willing and able to give consent

排除标准

  • 1) Patients with a significant condition which will affect their clinical status such as terminal malignancy, HIV infection, etc
  • 2) Pregnant patients
  • 3) Patients unable to complete the Kansas City Cardiomyopathy Questionnaire, PHQ9 Questionnaire, or a 6-minute walk test
  • 4) Patients that underwent a major change in clinical status including hospitalization or introduction of a new heart failure medication over the last month.

研究者

发起方
Professor Andrew Sindone

相似试验